Friday, June 24, 2011

MoNews 6/24/11

Prostate Cancer Treatment Study: Immunotherapy Drug Treatments for Prostate Cancer - Progress and Setbacks - SMART Surgery
- researchers have dreamed of curing prostate cancer with targeted drugs
- Recent approvals of immuno-modulatory drugs Provenge and Yervoy represent considerable progress in this domain, as they have already been shown to improve survival rates in certain types of metastatic prostate cancer
- "There is no doubt that these drugs represent a great scientific accomplishment. However, they do not eradicate all of the cancer cells in the body. They do delay prostate cancer recurrence but, eventually, the disease can become resistant to their effects."
- In contrast to these new drugs, robotic prostatectomy has been shown to provide one of the highest prostate cure rates of any primary treatment.
- Using SMART Surgery (Samadi Modified Advanced Robotic Technique), Dr. Samadi is able to preserve the delicate nerve bundles responsible for urinary control and sexual function. This technique not only cures cancer in 97% of his patients, but also preserves sexual and urinary function among 85% and 96% of his patients, respectively.
- "While the new drugs can put up a good fight against prostate cancer, there's only one way to win the war against this disease, and that's surgery"
 

No comments:

Post a Comment